Faropenem, a highly efficacious and orally bioavailable beta-lactam antibiotic, exhibits an extensive range of in vitro antimicrobial activity against diverse gram-positive and -negative aerobes and anaerobes. Notably, Faropenem possesses inherent resistance to hydrolysis by virtually all beta-lactamases, including extended-spectrum beta-lactamases and AmpC beta-lactamases. Moreover, Faropenem has been developed as an oral prodrug, namely faropenem medoxomil, for the investigation of respiratory tract infections.
Faropenem sodium hemipentahydrate is an orally administered beta-lactam antibiotic within the penem group, exhibiting resistance to certain types of extended-spectrum beta-lactamase (beta-lactamase).
Faropenem-d7 Sodium Salt 是 Faropenem Sodium Salt 的氘代化合物。Faropenem Sodium Salt 的 CAS 号为 122547-49-3。Faropenem sodium 是一种口服生物可利用的青霉烯类抗生素,能有效杀灭结核分枝杆菌,治疗结核病和社区获得性肺炎。